Momenta Pharmaceuticals Inc (NASDAQ:MNTA)

During the Trading Day
20.13 +0.04 / +0.20%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
20.12 -0.01 / -0.05%
 
Volume: 13.1K

Stock Price Forecast

The 9 analysts offering 12-month price forecasts for Momenta Pharmaceuticals Inc have a median target of 17.00, with a high estimate of 25.00 and a low estimate of 7.00. The median estimate represents a -15.55% decrease from the last price of 20.13.

Analyst Recommendations

The current consensus among 9 polled investment analysts is to Buy stock in Momenta Pharmaceuticals Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.45
Sales
$12.1M
Reporting Date
May 01

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly -44.16%
 
 
 
 
 
 
Growthannually 79.35%
 
 
 
 
 
 

Sales

Growthquarterly -42.95%
 
 
 
 
 
 
Growthannually 144.68%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account